Trial reportEpidemiology and infection2019
Burden of gastrointestinal illness in Sweden-SMS as a tool for collecting self-reported gastrointestinal illness.
Trial report in Epidemiology and infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence and distribution of acute gastrointestinal illness in the community of China: a population-based face-to-face survey, 2014-2015.BMC public health · 2023Article
- A population-based survey of the prevalence of self-reported acute gastrointestinal illness in Zhejiang Province, China.PloS one · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We collected monthly reports on gastrointestinal illness (GII) episodes among 2348 adults in a 1-year cohort in South West Sweden. The GII episodes were collected by SMS (Short Message System) and validated by telephone interviews among the cohort participants and nationwide. The annual incidence was 0.64 and 0.43 cases per person-year for 28-day self-defined GII (any symptom) and acute GII (vomiting and/or ≥3 episodes of diarrhoea), respectively. The incidence was about 20% higher for the 14-day recall, compared with 28-day recall. The duration of illness was on average 2.3 days. We observed a unimodal seasonal distribution of GII, with the highest prevalence during winter. Responses collected by SMS highly correlated with responses collected by telephone. SMS survey was an efficient tool for the collection of repeated estimates of GII.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.